IL6 and diabetes mellitus: A report has indicated that the overexpression of miR-342-3p following inhibition of NEAT1 decreases the release of the inflammatory cytokines IL-6, IL-1β, TNF-α, and cyclooxygenase-2 in type 1 diabetes mellitus [36].